Escalier Biosciences Scores $19 Million in Funding Supporting Therapies for Psoriasis and Other Autoimmune Diseases

Escalier Biosciences and its dermatologic and autoimmune targets received a $19 million series B round funding from European Venture Capital firms Forbion, New Science Ventures and BioGeneration. 

“Escalier’s team has an impressive track record of developing novel compounds targeting diseases with significant unmet medical need,” stated Marco Boorsma, general partner at Forbion who will join Escalier’s board for financing. “We are excited to participate in this financing with New Science Ventures and BioGeneration Ventures and in supporting Escalier’s efforts to develop best-in-class drugs for the treatment of psoriasis and other autoimmune diseases.” 

The nuclear hormone receptor RORγt has emerged as the master regulator of Th17 cell differentiation and the production of pro-inflammatory cytokines. The funding will be used to create small molecule inhibitors of RORγt to lower the production of IL-17 in immune cells. Escalier is also developing both topical and oral RORγt drug candidates for psoriasis, and looks to begin clinicals with its topical compound in 2018.[1] 

“RORγt is a validated target for psoriasis and other autoimmune disorders and our drug candidates have the potential to provide the desired efficacy and safety in psoriasis patients that is currently unavailable with other topical or oral drugs,” said Raju Mohan, Ph.D., Chief Executive Officer of Escalier. “We are incredibly fortunate to have such a supportive syndicate of investors that share our passion in developing novel therapies for challenging targets such as RORγt.”

[1]https://www.prnewswire.com/news-releases/escalier-biosciences-raises-19-million-to-develop-its-topical-and-systemic-rort-therapies-for-psoriasis-and-other-autoimmune-diseases-300613033.html

Follow us on social media for the latest updates in B2B!

Image

Latest

Exceptional Customer Service in Healthcare is the Cornerstone of Building Patient Trust
November 12, 2024

The significance of excellent customer service in every corner and industry cannot be overstated. This notion is especially crucial in healthcare, where patient experiences often influence their recovery and overall well-being. The topic of customer service in the medical field is always a priority in healthcare because providers strive to enhance patient satisfaction and…

Read More
eVTOL certification
Safran’s AI, Telemetry, and Data Precision Pave the Way for eVTOL Certification
November 11, 2024

The electric vertical takeoff and landing (eVTOL) industry is set to transform urban transportation by addressing congestion and promoting sustainable travel options. Experts predict the global eVTOL market will surge to $39 billion by 2033, with a compound annual growth rate (CAGR) of 36.8% over the next decade. This rapid expansion is fueled by…

Read More
A Plan for the Future: A Legacy of Love, Giving from a Grand Dad with Ken Bissell
November 11, 2024

Everyone knows that parenting is not an easy feat, but raising twins takes parenting to another level. Such a journey is one that Ken Bissell had with his wife and now stands to showcase the power of partnership, patience, and resilience in family life. Including his twins, Bissell is a father to a total…

Read More
Fighting for Fair Healthcare Access Means Overcoming Certain Challenges
November 8, 2024

With healthcare costs continuing to climb, and the access to quality care remaining uneven, discussions on healthcare reform are quite an essential topic. Millions of Americans face high out-of-pocket costs and limited access to critical health services. According to a 2022 Gallup poll, nearly 40 percent of Americans have delayed medical care due to…

Read More